Imedex, Inc: New Developments in Cancer Management 2006

JavaScript Disabled
This site uses JavaScript technology. Instructions are available to enable your browser's JavaScript ability.

CONTENTS

· Invitation
· Faculty
· Scientific Agenda
· CME
· Who Should Attend?
· Objectives
· Call for Abstracts
· Register
· General Information
· Hotel Accomodations
· Organizer

CORPORATE SUPPORT
The following company has provided a restricted educational grant in support of this conference:

PLATINUM

Amgen

SILVER

Merk Frosst

Roche

BRONZE

CORPORATE

EXHIBITOR

Bristol

Ortho

Pfizer

SUPPORT OPPORTUNITIES

Several options are available to companies interested in supporting this conference. For more information, please contact Courtney Burbridge at +1 (770) 751 7332, or by email

OCTOBER 4 - 6, 2006
Princess Margaret Hospital Conference
New Developments in Cancer Management
Toronto, Ontario, Canada

Chair:
Ronald Feld, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Conveners:
Ronald Feld, MD
Mary Gospodarowicz, MD
Jonathan C. Irish, MD
Armand Keating, MD
Hans Messner, MD

Organizing Committee:
Andrea Bezjak, MD
James Brierley, MD
John Cho, MD
Ronald Feld, MD
Neil Fleshner, MD
David Hedley, MD
Jonathan C. Irish, MD
John Kim, MD
Jennifer Knox, MD
Ann Koch,MD

Natasha Leighl, MD
Hans Messner, MD
Joseph Mikhael, MD
Martin O’Malley, MD
Amit M. Oza, MD
Ian Quirt, MD
Frances A. Shepherd, MD
Lillian Siu, MD
David Warr, MD
Janice Wright, RN, MN, ACNP

I N V I T A T I O N

Dear Colleagues:
On behalf of the Organizing Committee, it is with great pleasure that we invite you to participate in the 6th Princess Margaret Hospital Conference: New Developments in Cancer Management, to be held October 4 - 6, 2006 in Toronto, Ontario, Canada.

Year after year, this conference enjoys great success, as indicated by participant evaluations. Attendees have offered praise for the quality of the scientific program and the speakers, and state that participation in the conference greatly enhances their knowledge of state-of-the-art cancer research and management.

This year, the Committee has organized yet another excellent program aimed at updating attendees on standard cancer therapies, new experimental programs and advances in supportive care. The general focus of the discussions is to highlight how new information may apply to the treatment of cancer patients in your own institution or practice setting. The distinguished faculty includes members of the Princess Margaret Hospital community, one of the largest multidisciplinary cancer centers in North America and a pioneer in basic research and development of new cancer treatments. In addition, the program will feature international experts in various fields of oncology.

We are particularly proud to hold this meeting in the city of Toronto, one of the most beautiful and safest cities in North America. You will have the opportunity to visit at a time when the leaves are turning and the temperatures are usually pleasant with plenty of sunshine. Excellent museums and other interesting sites abound throughout the city, which is also located less than two hours from Niagara Falls, one of the natural wonders of the world. Because of the city’s multicultural character, there are plenty of restaurant choices to sample cuisine that is among the best in the world. We hope you will make time to partake in all the city has to offer while updating your knowledge in state-of-the-art cancer research and management.

We look forward to welcoming you to Toronto in October 2006!

Sincerely,
Ronald Feld, MD
Mary Gospodarowicz, MD
Jonathan Irish, MD
Armand Keating, MD
Hans Messner, MD
Conveners

F A C U L T Y

Andrea Bezjak, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Robert Buckman, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Ronald Burkes, MD
Mount Sinai Hospital
Toronto, Ontario, Canada

Pamela Catton, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

John Cho, MD, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

Mark Clemons, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Juanita M. Crook, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Michael R. Crump, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Jason E. Dodge, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Susan Done, MD
Toronto General Hospital
Toronto, Ontario, Canada

Ronald Feld, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Neil Fleshner, MD, MPH
University of Toronto
Toronto, Ontario, Canada

Tony Fyles, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

David Gianfelice, MD
University of Toronto
Toronto, Ontario, Canada

Masoom Haider, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Jan Hauspy, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

David H. Ilson, MD, PhD
Memorial Sloan-Kettering
Cancer Center
New York, New York
United States

Jonathan Irish, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

David A. Jaffray, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

Shaf Keshavjee, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

John Kim, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Jennifer Knox, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Walter Kucharczyk, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

John Kuruvilla, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Stephane Laframboise, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Normand Laperriere, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Natasha Leighl, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Wilfred Levin, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Helen MacKay, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Lee Manchul, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

David R. McCready, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Hans Messner, MD, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

Joseph Mikhael, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Michael Milosevic, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Malcolm J. Moore, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Joan Murphy, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Susan O’Brien, MD
MD Anderson Cancer Center
Houston, Texas, United States

Martin O'Malley, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Laura Rashleigh, RN
Princess Margaret Hospital
Toronto, Ontario, Canada

Donna Reece, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Heidi Roberts, MD
University of Toronto
Toronto, Ontario, Canada

Susan Robinson, RN, MS
Princess Margaret Hospital
Toronto, Ontario, Canada

Prisco Salvador, RN, MScN
Princess Margaret Hospital
Toronto, Ontario, Canada

Pamela Savage, RN, MEd
Princess Margaret Hospital
Toronto, Ontario, Canada

Aaron D. Schimmer, MD, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

Jeff H. Siewerdsen, PhD
University of Toronto
Toronto, Ontario, Canada

Walter M. Stadler, MD
University of Chicago Hospitals
Chicago, Illinois
United States

Ian F. Tannock, MD, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

John Trachtenberg, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Janette Vardy, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

David Warr, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Alice C. Wei, MD
Toronto General Hospital
Toronto, Ontario, Canada

Stephen Welch, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Barb Willson, RN
Princess Margaret Hospital
Toronto, Ontario, Canada

Michael Wong, MD, PhD
Roswell Park Cancer Center
Buffalo, New York
United States

Rebecca K.S. Wong, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Cameron D. Wright, MD
Massachusetts General Hospital Harvard Medical School
Boston, Massachusetts
United States

Janice Wright, RN, MS
Princess Margaret Hospital
Toronto, Ontario, Canada

Karen W.L. Yee, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

S C I E N T I F I C A G E N D A

Wednesday, October 4, 2006
8:30 am	Welcome and introduction Ronald Feld, MD
8:40 am	Keynote lecture: Advanced medical imaging systems and high precision radiation treatment David A. Jaffray, PhD
9:40 am	Coffee break

	Session I: Malignant hematology I Chair: Donna Reece, MD
10:00 am	T-cell lymphoma Michael R. Crump, MD
10:15 am	Questions
10:20 am	Maintenance therapy for lymphoma John Kuruvilla, MD
10:35 am	Questions
10:40 am	Multiple myeloma Joseph Mikhael, MD
10:55 am	Questions

	Session II: Genitourinary malignancies Chair: Jennifer Knox, MD
11:05 am	Update on prostate cancer detection: What happened to PSA? Neil Fleshner, MD, MPH
11:15 am	Questions
11:20 am	Prostate brachytherapy 1986-2006. Where are we now? Juanita M. Crook, MD
11:30 am	Questions
11:35 am	Novel tyrosine kinase inhibitors in renal cancer: Reason for hope Walter M. Stadler, MD
11:50 am	Questions
11:55 am	Debate: There is still a role for immunotherapy in first line treatment of metastatic kidney cancer Pro: Michael Wong, MD, PhD Con: Ian F. Tannock, MD, PhD
12:15 pm	Rebuttals
12:25 pm	Questions
12:35 pm	Lunch

	Session III: Supportive care Chair: David Warr, MD
1:50 pm	Beyond whole brain radiotherapy: Novel strategies Normand Laperriere, MD
2:05 pm	Questions
2:10 pm	"Chemo brain"- Underlying mechanisms, natural history, and possible interventions Janette Vardy, MD
2:25 pm	Questions
2:30 pm	Communication, communication, communication Robert Buckman, MD
2:45 pm	Questions
2:50 pm	Survivorship programs in breast cancer: What is the evidence that these programs work? Pamela Catton, MD
3:05 pm	Questions
3:10 pm	Break

CONCURRENT SESSIONS
	Session IVa: Special surgical session Chair: Jonathan C. Irish, MD
3:30 pm	Guided therapeutics: How radiation physics, cancer surgery, and diagnostic imaging can come together David A. Jaffray, PhD
3:40 pm	Questions
3:45 pm	Surgical sharpshooting: Use of real-time, intraoperative imaging for cancer surgery (using lung, head and neck/skull base) Jeff H. Siewerdsen, PhD
4:05 pm	Questions
4:10 pm	Guided therapeutics and innovative treatments for prostate cancer John Trachtenberg, MD Walter Kucharczyk, MD Masoom Haider, MD
4:40 pm	Questions

	Concurrent session IVb: Nursing session I Chair: Janice Wright, RN, MS
3:30 pm	Knowledge, Attitudinal, Experiential Survey on Advance Directives (KAESAD) Instrument^©: Study results Susan Robinson, RN, MS
3:45 pm	Questions
3:50 pm	Advanced care planning best practice guidelines and the role of oncology nurses Janice Wright RN, MS
4:10 pm	Questions
4:15 pm	Panel discussion: Advanced directives
4:45 pm	Questions

4:55 pm	Poster viewing and reception

Thursday, October 5, 2006
8:30 am	Welcome to day two Ronald Feld, MD

	Session V: Gastrointestinal malignancies Neoadjuvant therapies in gastrointestinal cancer: New frontiers Chair: John Kim, MD
8:35 am	Preoperative management of esophageal and stomach cancers David H. Ilson, MD, PhD
8:55 am	Questions
9:00 am	Image guided preoperative radiotherapy for carcinoma of the esophagus Rebecca K.S Wong, MD
9:15 am	Questions
9:20 am	Surgical management of upper gastrointestinal malignancies following chemotherapy and radiation Alice C. Wei, MD
9:35 am	Questions
9:40 am	Neoadjuvant strategies in carcinoma of the pancreas Malcolm J. Moore, MD
9:55 am	Questions
10:00 am	Break

CONCURRENT SESSIONS
	Concurrent session VIa: Medical imaging Chair: Martin O’Malley, MD
10:15 am	MRI guided focused ultrasound ablation: Clinical experience with breast carcinoma and future applications David Gianfelice, MD
10:30 am	Questions
10:40 am	Lung cancer screening: An update Heidi Roberts, MD
11:05 am	Questions

	Concurrent session VIb: Nursing session II: Clinical management update Chair: Barb Willson, RN
10:15 am	Wound and skin care update Pamela Savage, RN, MEd
10:30 am	Questions
10:35 am	Mucositis: Development of an oral care guide Prisco Salvatour, RN, MScN
10:50 am	Questions
10:55 am	Malignant Hematology Nursing Council: Effecting change for quality patient care Laura Rashleigh, RN
11:10 am	Questions


	Session VII: Malignant hematology II Chair: Hans Messner, MD, PhD
11:15 am	Chronic lymphocytic leukemia Susan O’Brien, MD
11:30 am	Questions
11:35 am	Myelodysplastic syndromes Karen W.L. Yee, MD
11:50 am	Questions
11:55 am	Acute leukemia Aaron D. Schimmer, MD, PhD
12:25 pm	Questions
12:35 pm	Lunch

	Session VIII: Lung cancer Chair: Ronald Burkes, MD
1:50 pm	Stereotactic RT for medically inoperable patients with non-small cell lung cancer Andrea Bezjak, MD
2:05 pm	Questions
2:10 pm	Advanced surgery for advanced lung cancer Shaf Keshavjee, MD
2:25 pm	Questions
2:30 pm	Multimodality management of thymomas Cameron D. Wright, MD
2:45 pm	Questions
2:50 pm	Management of small cell lung cancer in 2006 Natasha Leighl, MD
3:05 pm	Questions
3:10 pm	Break

	Session IX: Breast cancer Chair: Michael R. Crump
3:30 pm	Novel systemic therapy regimens in the treatment of locally advanced breast cancer Mark R. Clemons, MD
3:45 pm	Questions
3:50 pm	Neoadjuvant therapy in breast cancer: Pathologic predictors of treatment response Susan Done, MD
4:05 pm	Questions
4:10 pm	Surgical challenges in locally advanced breast cancer: Sentinel node biopsy, breast reconstruction David R. McCready, MD
4:25 pm	Questions
4:30 pm	Evolution and revolution in radiotherapy treatment in breast cancer (IMRT, APBI) John Cho, MD, PhD
4:45 pm	Questions
4:50 pm	Adjourn

Friday, October 6, 2006
8:30 am	Welcome to day three Ronald Feld, MD

	Session X: Gynecological malignancies Chairs: Michael Milosevic, MD and Joan Murphy, MD
8:35 am	Ovarian Cancer: IP therapy: What, why, when? Helen MacKay, MD
8:45 am	Questions
8:50 am	Ovarian cancer and IP therapy: Importance of debulking surgery Jason E. Dodge, MD
9:00 am	Questions
9:05 am	Ovarian cancer: Is there a role for surgery after recurrence? Jan Hauspy, MD
9:15 am	Questions
9:20 am	Ovarian cancer: Novel agents and trials Stephen Welch, MD
9:30 am	Questions
9:35 am	Interactive panel discussion and multidisciplinary case presentations Moderator: Lee Manchul, MD Participants: Tony Fyles, MD Stephane Laframboise, MD Wilfred Levin, MD Helen MacKay, MD
9:55 am	Break

	Session XI: Challenging cases Chair: Joseph Mikhael, MD
10:10 am	A case-based approach to recent major paradigm shifts in cancer treatment Moderator: Ronald Feld, MD
11:40 am	Evaluation and adjourn

C O N T I N U I N G M E D I C A L E D U C A T I O N

Imedex^®, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Imedex, Inc. designates this educational activity for a maximum of 15.0 category 1 credits toward the AMA Physician’s Recogni